A dispersion model for the hepatic uptake and elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin

Mathematical and Computer Modelling

Volumn 28, Issue 1, 1998, Pages 9-29

  Banks, H T ^a   Musante, C J ^a   Tran, H T ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin (TCDD); Delay equations.; Liver transport models; Nonlinear partial differential equations; Physiologically based pharmacokinetic (PBPK) model

Indexed keywords

EID: 0032126452     PISSN: 08957177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7177(98)00077-6     Document Type: Article

References (36)

1. 1. S.A. Skene, I.C. Dewhurst and M. Greenberg, Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans: The risks to human health, A review, Hum. Toxicol. 8, 173-203, (1989).
2. 2. M. Van den Berg, J. De Jongh, H. Poiger and J. Olson, The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity, Crit. Rev. Toxicol. 24, 1-74, (1994).
3. 3. A. Poland and E. Glover, Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol, J. Biol. Chem. 251 (16), 4936-4946, (1976).
4. 125I] 2-Iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: Characterization and identification, Mol. Pharmacol. 36, 113-120, (1989).
5. 5. R. Voorman and S.D. Aust, Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol-2-hydroxylase activity, Toxicol. Appl. Pharmacol. 90, 69-78, (1987).
6. 6. H.W. Leung, D. J. Paustenbach, F. J. Murray and M.E. Andersen, A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat, Toxicol. Appl. Pharmacol. 103, 399-410, (1990).
7. 7. H.W. Leung, R.H. Ku, D. J. Paustenbach and M.E. Andersen, A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice, Toxicol. Lett. 42, 15-28, (1988).
8. 8. M.S. Roberts and M. Rowland, A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations, J. Pharmacokinet. Biopharm. 14, 227-260, (1986).
9. 9. G.L. Henriksen, N.S. Ketchum, J.E. Michaelek and J.A. Swaby, Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand, Epidemiology 8 (3), 252-258, (1997).
10. 10. W.M. Copenhaver, E.K. Douglas and R.L. Wood, Bailey's Textbook of Histology, Seventeenth edition, Williams & Wilkins, Baltimore, MA, (1978).
11. 11. A.L. Jones and E. Spring-Mills, The liver and gall bladder, In Cell and Tissue Biology, A Textbook of Histology, Sixth edition, (Edited by L. Weiss), pp. 685-714, Urban & Schwarzenberg, Baltimore, MA, (1988).
12. 12. J.A. Timbrell, The liver as a target organ for toxicity, In Target Organ Toxicity, Volume I, (Edited by G.M. Cohen), pp. 145-173, CRC Press, Boca Raton, FL, (1986).
13. 13. D.L. Miller, C.S. Zanolli and J.J. Gumucio, Quantitative morphology of the sinusoids of the hepatic acinus: Quantimet analysis of the rat liver, Gastroenty 76, 965-969, (1979).
14. 14. O. Levenspiel, Chemical Reaction Engineering, John Wiley and Sons, New York, (1972).
15. 15. R.W. Fahien, Fundamentals of Transport Phenomena, McGraw-Hill, New York, (1983).
16. 16. J.Q. Rose, J.C. Ramsey, T.H. Wentzler, R.A. Hummel and P.J. Gehring, The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat, Toxicol. Appl. Pharmacol. 36, 209-226, (1976).
17. 17. J.C. Ramsey, J.G. Hefner, R.J. Krakowski, W.H. Braun and P.J. Gehring, The in vivo biotransformation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat, Toxicol. Appl. Pharmacol. 48 (A162), (1979).
18. 18. H. Poiger and H.R. Buser, The metabolism of TCDD in the dog and rat, In Banbury Report 18: Biological Mechanisms of Dioxin Action, (Edited by A. Poland and R.D. Kimbrough), pp. 39-46, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, (1984).
19. 19. L.B. Kedderis, J.J. Diliberto, P. Linko, J.A. Goldstein and L.S. Birnbaum, Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodi benzo-p-dioxin in the rat: biliary excretion and induction of cytochromes CYP1A1 and CYP1A2, Toxicol. Appl. Pharmacol. 111, 163-172, (1991).
20. 20. J.R. Olson, T.A. Gasiewicz and R.A. Neal, Tissue distribution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the golden Syrian hamster, Toxicol. Appl. Pharmacol. 56, 78-85, (1980).
21. 21. R. Neal, T. Gasiewicz, L. Geiger, J. Olson and T. Sawahata, Metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mammalian systems, In Banbury Report 18: Biological Mechanisms of Dioxin Action, (Edited by A. Poland and R.D. Kimbrough), pp. 49-57, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, (1984).
22. 22. H. Poiger and C.H. Schlatter, Pharmacokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in man, Chemosphere 15, 1489-1494, (1986).
23. 23. J.S. Nakai, M.J. Winhall, N.J. Bunce, R. Rosengren and S. Safe, Comparative kinetic study of the binding between 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands with the hepatic Ah receptors from several rodent species, J. Biochem. Toxicol. 9, 199-209, (1994).
24. 24. R. Rosengren, S. Safe and N.J. Bunce, Kinetics of the association of several tritiated polychlorinated dibenzo-p-dioxin and dibenzofuran congeners with hepatic cytosolic Ah receptor from the Wistar rat, Chem. Res. Toxicol. 5, 376-382, (1992).
25. 25. N.J. Bunce, J.P. Landers and S.H. Safe, Kinetic models for association of 2,3,7,8-tetrachlorodibenzo-p-dioxin with the Ah receptor, Archs. Biochem. Biophys. 267, 384-397, (1988).
26. 26. F.J. Doherty and R.J. Mayer, Intracellular Protein Degradation, Oxford University Press, New York, (1992).
27. 27. J.E. Kester and T.A. Gasiewicz, Characterization of the in vitro stability of the rat hepatic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin, Archs. Biochem. and Biophys. 252, 606-625, (1987).
28. 28. M.C. Kohn, G.W. Lucier, G.G. Clark, C. Sewall, A.M. Tritscher and C. Portier, A mechanistic model of effects of dioxin on gene expression in the rat liver, Toxicol. Appl. Pharmacol. 120, 138-154, (1993).
29. 29. T.C. Sloop and G.W. Lucier, Dose-dependent elevation of Ah receptor binding by TCDD in rat liver, Toxicol. Appl. Pharmacol. 88, 329-337, (1987).
30. 30. W.L. Roth, S. Ernst, L.W.D. Weber, L. Kerecsen and K.K. Rozman, A pharmacodynamically responsive model of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) transfer between liver and fat at low and high doses, Toxicol. Appl. Pharmacol. 127, 151-162, (1994).
31. 31. S.I. Fox, Human Physiology, Fourth edition, Wm. C. Brown Publishers, Dubuque, (1993).
32. 32. P.V. Danckwerts, Continuous flow systems, Chemical Engineering Science 2, 1-13, (1953).
33. 33. J.C. Matthews, Fundamentals of Receptor, Enzyme, and Transport Kinetics, CRC Press, Boca Raton, FL, (1991).
34. 34. A.R. Patton, Biochemical Energetics and Kinetics, W.B. Saunders Company, Philadelphia, PA, (1965).
35. 35. H.T. Banks and C.J. Musante, Well-posedness for a class of abstract nonlinear parabolic systems with time delay, In Nonlinear Analysis: Theory, Methods, and Applications, CRSC-TR97-30 (to appear).
36. 36. H.T. Banks, D.S. Gilliam and V.L. Shubov, Global solvability for damped second order systems with unbounded input operators, CRSC-TR93-10, Differential and Integral Equations 10, 309-332, (1997).